Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV001002321 | SCV001160214 | pathogenic | Polycystic kidney disease, adult type | 2019-01-06 | criteria provided, single submitter | clinical testing | The PKD1 c.3792C>A; p.Tyr1264Ter variant, to our knowledge, is not reported in the medical literature but is reported in the ADPKD mutation database (see link). This variant is absent from general population databases (1000 Genomes Project, Exome Variant Server, and Genome Aggregation Database), indicating it is not a common polymorphism. This variant induces an early termination codon and is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Based on available information, the p.Tyr1264Ter variant is considered to be pathogenic. References: Link to ADPKD mutation database: http://pkdb.mayo.edu/cgi-bin/v2_desig_display.cgi?germ=Germline&gene=PKD1&designation=Y1264X&clinical=Definitely%20Pathogenic&score=&gene_mutation_id=2158&apkd_mode=PROD&username= |